Message :
Required fields
Achieved primary endpoint demonstrating significant correlation between DetermaIO and two-year overall survival rate to atezolizumab in metastatic bladder cancer
DetermaIO identified additional immunotherapy responsive patients missed by commonly used biomarkers
Data supports potential utility of DetermaIO test across multiple solid tumors as predictor of response to Immune Checkpoint Inhibitor therapy in estimated $3 billion market in the United States
KOL Webinar discussing results to be held on April 19 at 11:30 AM EDT/8:30 AM PDT
IRVINE, Calif., April 10, 2021 (GLOBE NEWSWIRE) Oncocyte Corporation (Nasdaq: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, presented new data at the American Association for Cancer Research (AACR) Annual Meeting 2021, being held virtually from April 10-15, 2021. The presentations featured studies of Oncocyte’s novel
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Monday, April 5, 2021 | Sacramento, CA
At his clinic in East Los Angeles, Dr. Efrain Talamantes recently saw three patients all seniors with dementia who hadn’t visited his office in more than a year. Finally seeing them in-person, after they were vaccinated, felt like a huge victory. But Talamantes worries that many patients have slipped through the cracks, endangering their health by delaying care for their diseases during the pandemic.
“As we focus on recovery, we have to ensure that we get vaccinated,” Talamantes said, “but also that we have a concerted effort to manage the chronic diseases that haven’t received the attention required to avoid complications.”
Doctors fear the year-long delays in medical care could lead to early deaths and severe health problems Author: Ana Ibarra (CalMatters), CALmatters Published: 4:47 PM PDT April 5, 2021 Updated: 5:13 PM PDT April 5, 2021
CALIFORNIA, USA
This story was originally published by CalMatters. Lea este artículo en español.
At his clinic in East Los Angeles, Dr. Efrain Talamantes recently saw three patients all seniors with dementia who hadn’t visited his office in more than a year. Finally seeing them in-person, after they were vaccinated, felt like a huge victory. But Talamantes worries that many patients have slipped through the cracks, endangering their health by delaying care for their diseases during the pandemic.
Good morning, California! It’s Monday, April 5.
I’m CalMatters politics reporter Ben Christopher, filling in for Emily Hoeven, who is enjoying a much-deserved week off.
A “gold rush” amid the calamity
This much is not news: California’s Employment Development Department, the state agency responsible for shelling out unemployment claims to millions of jobless Californians, is still a mess.
Since the beginning of the pandemic, the department has spent $236 million on contract workers, software upgrades and other patches to its overburdened and frayed system. With a little digging, Hepler found that nearly half of that $103.8 million went to just five vendors, some in the form of no-bid contracts.